{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T00:41:36Z","timestamp":1785199296810,"version":"3.55.0"},"reference-count":82,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,7,2]]},"DOI":"10.7759\/cureus.63671","type":"journal-article","created":{"date-parts":[[2024,7,2]],"date-time":"2024-07-02T15:28:52Z","timestamp":1719934132000},"source":"Crossref","is-referenced-by-count":4,"title":["Emerging Treatments and Therapies for Autism Spectrum Disorder: A Narrative Review"],"prefix":"10.7759","author":[{"given":"Alan D","family":"Kaye","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaitlyn  E","family":"Allen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Van  S","family":"Smith III","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria T","family":"Tong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivian  E","family":"Mire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huy","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zachary","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Kouri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Jean Baptiste","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chizoba  N","family":"Mosieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam M","family":"Kaye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giustino","family":"Varrassi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sahar","family":"Shekoohi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.4103\/psychiatry.IndianJPsychiatry_542_18","article-title":"Clinical practice guidelines for autism spectrum disorders","volume":"61","author":"Subramanyam AA","year":"2019","unstructured":"Subramanyam AA, Mukherjee A, Dave M, Chavda K. Clinical practice guidelines for autism spectrum disorders. Indian J Psychiatry. 2019, 61:254-69. 10.4103\/psychiatry.IndianJPsychiatry_542_18","journal-title":"Indian J Psychiatry"},{"key":"ref2","article-title":"Autism spectrum disorder","author":"Mughal S","year":"2022","unstructured":"Mughal S, Faizy RM, Saadabadi A. Autism spectrum disorder. StatPearls [Internet]. StatPearls Publishing, Treasure Island (FL); 2022."},{"key":"ref3","article-title":"National Center on Birth Defects and Developmental Disabilities (Centers for Disease Control and Prevention). Office of the Director. (2015). National Center on Birth Defects and Develomental Disabilities fiscal year 2014 annual report","year":"2015","unstructured":"National Center on Birth Defects and Developmental Disabilities Fiscal Year 2014 Annual Report.  National Center on Birth Defects and Developmental Disabilities (Centers for Disease Control and Prevention), Atlanta, GA; 2015. https.\/\/stacks.cdc.gov\/view\/cdc\/28563."},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaac.2013.12.021","article-title":"A comparison of DSM-IV pervasive developmental disorder and DSM-5 autism spectrum disorder prevalence in an epidemiologic sample","volume":"53","author":"Kim YS","year":"2014","unstructured":"Kim YS, Fombonne E, Koh YJ, Kim SJ, Cheon KA, Leventhal BL. A comparison of DSM-IV pervasive developmental disorder and DSM-5 autism spectrum disorder prevalence in an epidemiologic sample. J Am Acad Child Adolesc Psychiatry. 2014, 53:500-8. 10.1016\/j.jaac.2013.12.021","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.3109\/17518421003793439","article-title":"Unsubstantiated treatments for individuals with autism","volume":"13","author":"Davis TN","year":"2010","unstructured":"Davis TN. Unsubstantiated treatments for individuals with autism. Dev Neurorehabil. 2010, 13:231-3. 10.3109\/17518421003793439","journal-title":"Dev Neurorehabil"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.43226","article-title":"Early diagnosis of autism spectrum disorder: a review and analysis of the risks and benefits","volume":"15","author":"Okoye C","year":"2023","unstructured":"Okoye C, Obialo-Ibeawuchi CM, Obajeun OA, et al.. Early diagnosis of autism spectrum disorder: a review and analysis of the risks and benefits. Cureus. 2023, 15:e43226. 10.7759\/cureus.43226","journal-title":"Cureus"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2014.00058","article-title":"Predictors of outcomes in autism early intervention: why don't we know more?","volume":"2","author":"Vivanti G","year":"2014","unstructured":"Vivanti G, Prior M, Williams K, Dissanayake C. Predictors of outcomes in autism early intervention: why don't we know more?. Front Pediatr. 2014, 2:58. 10.3389\/fped.2014.00058","journal-title":"Front Pediatr"},{"key":"ref8","article-title":"Autism spectrum disorders: Diagnosis and treatment","author":"Lordan R","year":"2021","unstructured":"Lordan R, Storni C, De Benedictis CA. Autism spectrum disorders: Diagnosis and treatment. Autism Spectrum Disorders [Internet]. Grabrucker AM (ed): Exon Publications, Brisbane (AU); 2021."},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.cca.2019.12.009","article-title":"Biomarkers in autism spectrum disorders: current progress","volume":"502","author":"Shen L","year":"2020","unstructured":"Shen L, Liu X, Zhang H, Lin J, Feng C, Iqbal J. Biomarkers in autism spectrum disorders: current progress. Clin Chim Acta. 2020, 502:41-54. 10.1016\/j.cca.2019.12.009","journal-title":"Clin Chim Acta"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1176\/appi.books.9780890425596","article-title":"Diagnostic and statistical manual of mental disorders: DSM-5","year":"2013","unstructured":"Diagnostic and Statistical Manual of Mental Disorders. DSM-5. American Psychiatric Association, Arlington, VA; 2013. 10.1176\/appi.books.9780890425596"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2007-2362","article-title":"Management of children with autism spectrum disorders","volume":"120","author":"Myers SM","year":"2007","unstructured":"Myers SM, Johnson CP. Management of children with autism spectrum disorders. Pediatrics. 2007, 120:1162-82. 10.1542\/peds.2007-2362","journal-title":"Pediatrics"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1007\/s13311-022-01183-1","article-title":"An update on psychopharmacological treatment of autism spectrum disorder","volume":"19","author":"Aishworiya R","year":"2022","unstructured":"Aishworiya R, Valica T, Hagerman R, Restrepo B. An update on psychopharmacological treatment of autism spectrum disorder. Neurotherapeutics. 2022, 19:248-62. 10.1007\/s13311-022-01183-1","journal-title":"Neurotherapeutics"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1037\/\/0022-006x.55.1.3","article-title":"Behavioral treatment and normal educational and intellectual functioning in young autistic children","volume":"55","author":"Lovaas OI","year":"1987","unstructured":"Lovaas OI. Behavioral treatment and normal educational and intellectual functioning in young autistic children. J Consult Clin Psychol. 1987, 55:3-9. 10.1037\/\/0022-006x.55.1.3","journal-title":"J Consult Clin Psychol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2013.00019","article-title":"Physical therapy for young children diagnosed with autism spectrum disorders-clinical frameworks model in an Israeli setting","volume":"1","author":"Atun-Einy O","year":"2013","unstructured":"Atun-Einy O, Lotan M, Harel Y, Shavit E, Burstein S, Kempner G. Physical therapy for young children diagnosed with autism spectrum disorders-clinical frameworks model in an Israeli setting. Front Pediatr. 2013, 1:19. 10.3389\/fped.2013.00019","journal-title":"Front Pediatr"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.3390\/children9101584","article-title":"Interventions for sensory over-responsivity in individuals with autism spectrum disorder: a narrative review","volume":"9","author":"Yuan HL","year":"2022","unstructured":"Yuan HL, Lai CY, Wong MN, Kwong TC, Choy YS, Mung SW, Chan CC. Interventions for sensory over-responsivity in individuals with autism spectrum disorder: a narrative review. Children (Basel). 2022, 9:1584. 10.3390\/children9101584","journal-title":"Children (Basel)"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijdevneu.2004.08.002","article-title":"Significance of abnormalities in developmental trajectory and asymmetry of cortical serotonin synthesis in autism","volume":"23","author":"Chandana SR","year":"2005","unstructured":"Chandana SR, Behen ME, Juh\u00e1sz C, et al.. Significance of abnormalities in developmental trajectory and asymmetry of cortical serotonin synthesis in autism. Int J Dev Neurosci. 2005, 23:171-82. 10.1016\/j.ijdevneu.2004.08.002","journal-title":"Int J Dev Neurosci"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1001\/archgenpsychiatry.2009.137","article-title":"Brain serotonin and dopamine transporter bindings in adults with high-functioning autism","volume":"67","author":"Nakamura K","year":"2010","unstructured":"Nakamura K, Sekine Y, Ouchi Y, et al.. Brain serotonin and dopamine transporter bindings in adults with high-functioning autism. Arch Gen Psychiatry. 2010, 67:59-68. 10.1001\/archgenpsychiatry.2009.137","journal-title":"Arch Gen Psychiatry"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1007\/s10803-010-0996-9","article-title":"The heavy burden of psychiatric comorbidity in youth with autism spectrum disorders: a large comparative study of a psychiatrically referred population","volume":"40","author":"Joshi G","year":"2010","unstructured":"Joshi G, Petty C, Wozniak J, et al.. The heavy burden of psychiatric comorbidity in youth with autism spectrum disorders: a large comparative study of a psychiatrically referred population. J Autism Dev Disord. 2010, 40:1361-70. 10.1007\/s10803-010-0996-9","journal-title":"J Autism Dev Disord"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1089\/cap.2020.0110","article-title":"Psychotropic polypharmacy among children and youth with autism: a systematic review","volume":"31","author":"Ritter C","year":"2021","unstructured":"Ritter C, Hewitt K, McMorris CA. Psychotropic polypharmacy among children and youth with autism: a systematic review. J Child Adolesc Psychopharmacol. 2021, 31:244-58. 10.1089\/cap.2020.0110","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.5409\/wjcp.v10.i3.15","article-title":"Autism medical comorbidities","volume":"10","author":"Al-Beltagi M","year":"2021","unstructured":"Al-Beltagi M. Autism medical comorbidities. World J Clin Pediatr. 2021, 10:15-28. 10.5409\/wjcp.v10.i3.15","journal-title":"World J Clin Pediatr"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.3390\/brainsci5020092","article-title":"Autism spectrum disorder (ASD) and fragile X syndrome (FXS): Two overlapping disorders reviewed through electroencephalography\u2014What can be interpreted from the available information?","volume":"5","author":"Devitt NM","year":"2015","unstructured":"Devitt NM, Gallagher L, Reilly RB. Autism spectrum disorder (ASD) and fragile X syndrome (FXS): Two overlapping disorders reviewed through electroencephalography\u2014What can be interpreted from the available information?. Brain Sci. 2015, 5:92-117. 10.3390\/brainsci5020092","journal-title":"Brain Sci"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1111\/dmcn.13217","article-title":"Prevalence of autism and attention-deficit-hyperactivity disorder in Down syndrome: a population-based study","volume":"59","author":"Oxelgren UW","year":"2017","unstructured":"Oxelgren UW, Myrelid \u00c5, Anner\u00e9n G, et al.. Prevalence of autism and attention-deficit-hyperactivity disorder in Down syndrome: a population-based study. Dev Med Child Neurol. 2017, 59:276-83. 10.1111\/dmcn.13217","journal-title":"Dev Med Child Neurol"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1007\/s10072-018-3341-2","article-title":"Autism spectrum disorders are prevalent among patients with dystrophinopathies","volume":"39","author":"Fujino H","year":"2018","unstructured":"Fujino H, Saito T, Matsumura T, Shibata S, Iwata Y, Fujimura H, Imura O. Autism spectrum disorders are prevalent among patients with dystrophinopathies. Neurol Sci. 2018, 39:1279-82. 10.1007\/s10072-018-3341-2","journal-title":"Neurol Sci"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1016\/S2215-0366(19)30289-5","article-title":"Prevalence of co-occurring mental health diagnoses in the autism population: a systematic review and meta-analysis","volume":"6","author":"Lai MC","year":"2019","unstructured":"Lai MC, Kassee C, Besney R, et al.. Prevalence of co-occurring mental health diagnoses in the autism population: a systematic review and meta-analysis. Lancet Psychiatry. 2019, 6:819-29. 10.1016\/S2215-0366(19)30289-5","journal-title":"Lancet Psychiatry"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2022.837424","article-title":"ASD and ADHD comorbidity: what are we talking about?","volume":"13","author":"Hours C","year":"2022","unstructured":"Hours C, Recasens C, Baleyte JM. ASD and ADHD comorbidity: what are we talking about?. Front Psychiatry. 2022, 13:837424. 10.3389\/fpsyt.2022.837424","journal-title":"Front Psychiatry"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.2217\/fnl-2017-0030","article-title":"Comorbid autism spectrum disorder and anxiety disorders: a brief review","volume":"13","author":"Zaboski BA","year":"2018","unstructured":"Zaboski BA, Storch EA. Comorbid autism spectrum disorder and anxiety disorders: a brief review. Future Neurol. 2018, 13:31-7. 10.2217\/fnl-2017-0030","journal-title":"Future Neurol"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.4103\/1817-1745.174438","article-title":"Autism and sleep disorders","volume":"10","author":"Devnani PA","year":"2015","unstructured":"Devnani PA, Hegde AU. Autism and sleep disorders. J Pediatr Neurosci. 2015, 10:304-7. 10.4103\/1817-1745.174438","journal-title":"J Pediatr Neurosci"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1016\/j.chc.2019.02.009","article-title":"Depression in youth with autism spectrum disorder","volume":"28","author":"Pezzimenti F","year":"2019","unstructured":"Pezzimenti F, Han GT, Vasa RA, Gotham K. Depression in youth with autism spectrum disorder. Child Adolesc Psychiatr Clin N Am. 2019, 28:397-409. 10.1016\/j.chc.2019.02.009","journal-title":"Child Adolesc Psychiatr Clin N Am"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1002\/aur.2132","article-title":"Epilepsy and autism severity: a study of 6,975 children","volume":"12","author":"Ewen JB","year":"2019","unstructured":"Ewen JB, Marvin AR, Law K, Lipkin PH. Epilepsy and autism severity: a study of 6,975 children. Autism Res. 2019, 12:1251-9. 10.1002\/aur.2132","journal-title":"Autism Res"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1002\/aur.2624","article-title":"The challenge of detecting adverse events in adults with autism spectrum disorder who have intellectual disability","volume":"15","author":"Ballester P","year":"2022","unstructured":"Ballester P, Espadas C, Londo\u00f1o AC, et al.. The challenge of detecting adverse events in adults with autism spectrum disorder who have intellectual disability. Autism Res. 2022, 15:192-202. 10.1002\/aur.2624","journal-title":"Autism Res"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2019.12.020","article-title":"The gut microbiota is associated with psychiatric symptom severity and treatment outcome among individuals with serious mental illness","volume":"264","author":"Madan A","year":"2020","unstructured":"Madan A, Thompson D, Fowler JC, et al.. The gut microbiota is associated with psychiatric symptom severity and treatment outcome among individuals with serious mental illness. J Affect Disord. 2020, 264:98-106. 10.1016\/j.jad.2019.12.020","journal-title":"J Affect Disord"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.5498\/wjp.v11.i9.605","article-title":"Gastrointestinal disease in children with autism spectrum disorders: etiology or consequence?","volume":"11","author":"Krigsman A","year":"2021","unstructured":"Krigsman A, Walker SJ. Gastrointestinal disease in children with autism spectrum disorders: etiology or consequence?. World J Psychiatry. 2021, 11:605-18. 10.5498\/wjp.v11.i9.605","journal-title":"World J Psychiatry"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1002\/aur.2354","article-title":"Developmental-behavioral profiles in children with autism spectrum disorder and co-occurring gastrointestinal symptoms","volume":"13","author":"Restrepo B","year":"2020","unstructured":"Restrepo B, Angkustsiri K, Taylor SL, et al.. Developmental-behavioral profiles in children with autism spectrum disorder and co-occurring gastrointestinal symptoms. Autism Res. 2020, 13:1778-89. 10.1002\/aur.2354","journal-title":"Autism Res"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1001\/jamapediatrics.2021.1329","article-title":"Medication use in the management of comorbidities among individuals with autism spectrum disorder from a large nationwide insurance database","volume":"175","author":"Feroe AG","year":"2021","unstructured":"Feroe AG, Uppal N, Guti\u00e9rrez-Sacrist\u00e1n A, et al.. Medication use in the management of comorbidities among individuals with autism spectrum disorder from a large nationwide insurance database. JAMA Pediatr. 2021, 175:957-65. 10.1001\/jamapediatrics.2021.1329","journal-title":"JAMA Pediatr"},{"key":"ref35","article-title":"Pharmacological therapies for autism spectrum disorder: a review","volume":"40","author":"LeClerc S","year":"2015","unstructured":"LeClerc S, Easley D. Pharmacological therapies for autism spectrum disorder: a review. P T. 2015, 40:389-97.","journal-title":"P T"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1016\/j.yfrne.2011.07.001","article-title":"Prosocial effects of oxytocin and clinical evidence for its therapeutic potential","volume":"32","author":"Striepens N","year":"2011","unstructured":"Striepens N, Kendrick KM, Maier W, Hurlemann R. Prosocial effects of oxytocin and clinical evidence for its therapeutic potential. Front Neuroendocrinol. 2011, 32:426-50. 10.1016\/j.yfrne.2011.07.001","journal-title":"Front Neuroendocrinol"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.4260-08.2009","article-title":"Oxytocin makes a face in memory familiar","volume":"29","author":"Rimmele U","year":"2009","unstructured":"Rimmele U, Hediger K, Heinrichs M, Klaver P. Oxytocin makes a face in memory familiar. J Neurosci. 2009, 29:38-42. 10.1523\/JNEUROSCI.4260-08.2009","journal-title":"J Neurosci"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1016\/j.psyneuen.2009.04.002","article-title":"Oxytocin enhances the experience of attachment security","volume":"34","author":"Buchheim A","year":"2009","unstructured":"Buchheim A, Heinrichs M, George C, et al.. Oxytocin enhances the experience of attachment security. Psychoneuroendocrinology. 2009, 34:1417-22. 10.1016\/j.psyneuen.2009.04.002","journal-title":"Psychoneuroendocrinology"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuron.2008.04.009","article-title":"Oxytocin shapes the neural circuitry of trust and trust adaptation in humans","volume":"58","author":"Baumgartner T","year":"2008","unstructured":"Baumgartner T, Heinrichs M, Vonlanthen A, Fischbacher U, Fehr E. Oxytocin shapes the neural circuitry of trust and trust adaptation in humans. Neuron. 2008, 58:639-50. 10.1016\/j.neuron.2008.04.009","journal-title":"Neuron"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2009.09.020","article-title":"Intranasal oxytocin improves emotion recognition for youth with autism spectrum disorders","volume":"67","author":"Guastella AJ","year":"2010","unstructured":"Guastella AJ, Einfeld SL, Gray KM, Rinehart NJ, Tonge BJ, Lambert TJ, Hickie IB. Intranasal oxytocin improves emotion recognition for youth with autism spectrum disorders. Biol Psychiatry. 2010, 67:692-4. 10.1016\/j.biopsych.2009.09.020","journal-title":"Biol Psychiatry"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1312857110","article-title":"Oxytocin enhances brain function in children with autism","volume":"110","author":"Gordon I","year":"2013","unstructured":"Gordon I, Vander Wyk BC, Bennett RH, et al.. Oxytocin enhances brain function in children with autism. Proc Natl Acad Sci U S A. 2013, 110:20953-8. 10.1073\/pnas.1312857110","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1016\/j.neubiorev.2020.12.028","article-title":"Intranasal oxytocin in the treatment of autism spectrum disorders: A multilevel meta-analysis","volume":"122","author":"Huang Y","year":"2021","unstructured":"Huang Y, Huang X, Ebstein RP, Yu R. Intranasal oxytocin in the treatment of autism spectrum disorders: A multilevel meta-analysis. Neurosci Biobehav Rev. 2021, 122:18-27. 10.1016\/j.neubiorev.2020.12.028","journal-title":"Neurosci Biobehav Rev"},{"key":"ref43","article-title":"Pharmacological intervention for irritability, aggression, and self\u2010injury in autism spectrum disorder (ASD)","volume":"28","author":"Iffland M","year":"2023","unstructured":"Iffland M, Livingstone N, Jorgensen M, Hazell P, Gillies D. Pharmacological intervention for irritability, aggression, and self\u2010injury in autism spectrum disorder (ASD). Cochrane Database Syst Rev. 2023, 28:2023.","journal-title":"Cochrane Database Syst Rev"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1038\/tp.2012.124","article-title":"A randomised controlled trial of bumetanide in the treatment of autism in children","volume":"2","author":"Lemonnier E","year":"2012","unstructured":"Lemonnier E, Degrez C, Phelep M, et al.. A randomised controlled trial of bumetanide in the treatment of autism in children. Transl Psychiatry. 2012, 2:e202. 10.1038\/tp.2012.124","journal-title":"Transl Psychiatry"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaac.2020.07.888","article-title":"Bumetanide for core symptoms of autism spectrum disorder (BAMBI): a single center, double-blinded, participant-randomized, placebo-controlled, phase-2 superiority trial","volume":"60","author":"Sprengers JJ","year":"2021","unstructured":"Sprengers JJ, van Andel DM, Zuithoff NP, et al.. Bumetanide for core symptoms of autism spectrum disorder (BAMBI): a single center, double-blinded, participant-randomized, placebo-controlled, phase-2 superiority trial. J Am Acad Child Adolesc Psychiatry. 2021, 60:865-76. 10.1016\/j.jaac.2020.07.888","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1111\/apa.15723","article-title":"Bumetanide for autism: open-label trial in six children","volume":"110","author":"Fernell E","year":"2021","unstructured":"Fernell E, Gustafsson P, Gillberg C. Bumetanide for autism: open-label trial in six children. Acta Paediatr. 2021, 110:1548-53. 10.1111\/apa.15723","journal-title":"Acta Paediatr"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1111\/j.1651-2227.2010.01933.x","article-title":"The diuretic bumetanide decreases autistic behaviour in five infants treated during 3 months with no side effects","volume":"99","author":"Lemonnier E","year":"2010","unstructured":"Lemonnier E, Ben-Ari Y. The diuretic bumetanide decreases autistic behaviour in five infants treated during 3 months with no side effects. Acta Paediatr. 2010, 99:1885-8. 10.1111\/j.1651-2227.2010.01933.x","journal-title":"Acta Paediatr"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD013851.pub2","article-title":"Acetylcholinesterase inhibitors for autistic spectrum disorders","volume":"6","author":"Ure A","year":"2023","unstructured":"Ure A, Cox GR, Haslam R, Williams K. Acetylcholinesterase inhibitors for autistic spectrum disorders. Cochrane Database Syst Rev. 2023, 6:CD013851. 10.1002\/14651858.CD013851.pub2","journal-title":"Cochrane Database Syst Rev"},{"key":"ref49","article-title":"Treating autistic spectrum disorders in children: utility of the cholinesterase inhibitor rivastigmine tartrate","volume":"19","author":"Chez MG","year":"2004","unstructured":"Chez MG, Aimonovitch M, Buchanan T, Mrazek S, Tremb RJ. Treating autistic spectrum disorders in children: utility of the cholinesterase inhibitor rivastigmine tartrate. J Child Neurol. 2004, 19:165-9.","journal-title":"J Child Neurol"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2014.00087","article-title":"The use of medications approved for Alzheimer's disease in autism spectrum disorder: a systematic review","volume":"2","author":"Rossignol DA","year":"2014","unstructured":"Rossignol DA, Frye RE. The use of medications approved for Alzheimer's disease in autism spectrum disorder: a systematic review. Front Pediatr. 2014, 2:87. 10.3389\/fped.2014.00087","journal-title":"Front Pediatr"},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.1017\/S1461145712000880","article-title":"Memantine as adjunctive treatment to risperidone in children with autistic disorder: a randomized, double-blind, placebo-controlled trial","volume":"16","author":"Ghaleiha A","year":"2013","unstructured":"Ghaleiha A, Asadabadi M, Mohammadi MR, et al.. Memantine as adjunctive treatment to risperidone in children with autistic disorder: a randomized, double-blind, placebo-controlled trial. Int J Neuropsychopharmacol. 2013, 16:783-9. 10.1017\/S1461145712000880","journal-title":"Int J Neuropsychopharmacol"},{"key":"ref52","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-006-0518-9","article-title":"A retrospective study of memantine in children and adolescents with pervasive developmental disorders","volume":"191","author":"Erickson CA","year":"2007","unstructured":"Erickson CA, Posey DJ, Stigler KA, Mullett J, Katschke AR, McDougle CJ. A retrospective study of memantine in children and adolescents with pervasive developmental disorders. Psychopharmacology (Berl). 2007, 191:141-7. 10.1007\/s00213-006-0518-9","journal-title":"Psychopharmacology (Berl)"},{"key":"ref53","doi-asserted-by":"publisher","DOI":"10.1177\/0883073807302611","article-title":"Memantine as adjunctive therapy in children diagnosed with autistic spectrum disorders: an observation of initial clinical response and maintenance tolerability","volume":"22","author":"Chez MG","year":"2007","unstructured":"Chez MG, Burton Q, Dowling T, Chang M, Khanna P, Kramer C. Memantine as adjunctive therapy in children diagnosed with autistic spectrum disorders: an observation of initial clinical response and maintenance tolerability. J Child Neurol. 2007, 22:574-9. 10.1177\/0883073807302611","journal-title":"J Child Neurol"},{"key":"ref54","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD013845.pub2","article-title":"Memantine for autism spectrum disorder","volume":"8","author":"Brignell A","year":"2022","unstructured":"Brignell A, Marraffa C, Williams K, May T. Memantine for autism spectrum disorder. Cochrane Database Syst Rev. 2022, 8:CD013845. 10.1002\/14651858.CD013845.pub2","journal-title":"Cochrane Database Syst Rev"},{"key":"ref55","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2013.04.011","article-title":"The relationship of autism and gluten","volume":"35","author":"Buie T","year":"2013","unstructured":"Buie T. The relationship of autism and gluten. Clin Ther. 2013, 35:578-83. 10.1016\/j.clinthera.2013.04.011","journal-title":"Clin Ther"},{"key":"ref56","doi-asserted-by":"publisher","DOI":"10.1007\/s11011-018-0219-1","article-title":"Therapeutic use of carbohydrate-restricted diets in an autistic child; a case report of clinical and 18FDG PET findings","volume":"33","author":"\u017barnowska I","year":"2018","unstructured":"\u017barnowska I, Chrapko B, Gwizda G, Nocu\u0144 A, Mitosek-Szewczyk K, Gasior M. Therapeutic use of carbohydrate-restricted diets in an autistic child; a case report of clinical and 18FDG PET findings. Metab Brain Dis. 2018, 33:1187-92. 10.1007\/s11011-018-0219-1","journal-title":"Metab Brain Dis"},{"key":"ref57","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001903.pub5","article-title":"Ketogenic diets for drug-resistant epilepsy","volume":"6","author":"Martin-McGill KJ","year":"2020","unstructured":"Martin-McGill KJ, Bresnahan R, Levy RG, Cooper PN. Ketogenic diets for drug-resistant epilepsy. Cochrane Database Syst Rev. 2020, 6:CD001903. 10.1002\/14651858.CD001903.pub5","journal-title":"Cochrane Database Syst Rev"},{"key":"ref58","article-title":"The Ketogenic and Modified Atkins Diets: Treatments for Epilepsy and Other Disorders","author":"Kossoff EH","year":"2016","unstructured":"Kossoff EH, Turner Z, Doerrer S, Cervenka MC, Henry BJ. The Ketogenic and Modified Atkins Diets: Treatments for Epilepsy and Other Disorders. Demos Medical Publishing, LLC, New York, NY; 2016."},{"key":"ref59","doi-asserted-by":"publisher","DOI":"10.1007\/s11011-017-0088-z","article-title":"Ketogenic diet versus gluten free casein free diet in autistic children: a case-control study","volume":"32","author":"El-Rashidy O","year":"2017","unstructured":"El-Rashidy O, El-Baz F, El-Gendy Y, Khalaf R, Reda D, Saad K. Ketogenic diet versus gluten free casein free diet in autistic children: a case-control study. Metab Brain Dis. 2017, 32:1935-41. 10.1007\/s11011-017-0088-z","journal-title":"Metab Brain Dis"},{"key":"ref60","doi-asserted-by":"publisher","DOI":"10.3390\/medicina59091584","article-title":"A spectrum of solutions: unveiling non-pharmacological approaches to manage autism spectrum disorder","volume":"59","author":"Mondal A","year":"2023","unstructured":"Mondal A, Sharma R, Abiha U, Ahmad F, Karan A, Jayaraj RL, Sundar V. A spectrum of solutions: unveiling non-pharmacological approaches to manage autism spectrum disorder. Medicina (Kaunas). 2023, 59:1584. 10.3390\/medicina59091584","journal-title":"Medicina (Kaunas)"},{"key":"ref61","article-title":"The use of complementary alternative medicine in children and adolescents with autism spectrum disorder","volume":"48","author":"DeFilippis M","year":"2018","unstructured":"DeFilippis M. The use of complementary alternative medicine in children and adolescents with autism spectrum disorder. Psychopharmacol Bull. 2018, 48:40-63.","journal-title":"Psychopharmacol Bull"},{"key":"ref62","article-title":"U.S. Department of Health, Education, and Welfare Public Health Service","author":"Guy W","year":"1976","unstructured":"Guy W. ECDEU Assessment Manual for Psychopharmacology. U.S. Dept. of Health, Education, and Welfare, Public Health Service, Alcohol, Drug Abuse, and Mental Health Administration, National Institute of Mental Health, Psychopharmacology Research Branch, Division of Extramural Research Programs, Rockville, MD; 1976. https:\/\/openlibrary.org\/books\/OL24341821M\/ECDEU_assessment_manual_for_psychopharmacology."},{"key":"ref63","doi-asserted-by":"publisher","DOI":"10.1097\/00002060-200003000-00012","article-title":"UDS(MR)SM: follow-up data on patients discharged in 1994-1996. Uniform data system for medical rehabilitation","volume":"79","author":"Fiedler RC","year":"2000","unstructured":"Fiedler RC, Granger CV, Russell CF. UDS(MR)SM: follow-up data on patients discharged in 1994-1996. Uniform data system for medical rehabilitation. Am J Phys Med Rehabil. 2000, 79:184-92. 10.1097\/00002060-200003000-00012","journal-title":"Am J Phys Med Rehabil"},{"key":"ref64","article-title":"Pediatric Evaluation of Disability Inventory (PEDI): Development, Standardization and Administration Manual","author":"Haley SM","year":"1992","unstructured":"Haley SM. Pediatric Evaluation of Disability Inventory (PEDI): Development, Standardization and Administration Manual . New England Medical Center Hospital, PEDI Research Group, Pennsylvania, PA; 1992."},{"key":"ref65","doi-asserted-by":"publisher","DOI":"10.1089\/acm.2007.0823","article-title":"Electroacupuncture for children with autism spectrum disorder: pilot study of 2 cases","volume":"14","author":"Chen WX","year":"2008","unstructured":"Chen WX, Wu-Li L, Wong VC. Electroacupuncture for children with autism spectrum disorder: pilot study of 2 cases. J Altern Complement Med. 2008, 14:1057-65. 10.1089\/acm.2007.0823","journal-title":"J Altern Complement Med"},{"key":"ref66","article-title":"Randomized controlled trial of electro-acupuncture for autism spectrum disorder","volume":"15","author":"Wong VC","year":"2010","unstructured":"Wong VC, Chen WX. Randomized controlled trial of electro-acupuncture for autism spectrum disorder. Altern Med Rev. 2010, 15:136-46.","journal-title":"Altern Med Rev"},{"key":"ref67","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2023.942069","article-title":"Research status and prospects of acupuncture for autism spectrum disorders","volume":"14","author":"Li X","year":"2023","unstructured":"Li X, Li JC, Lu QQ, Zhang F, Zhang SQ. Research status and prospects of acupuncture for autism spectrum disorders. Front Psychiatry. 2023, 14:942069. 10.3389\/fpsyt.2023.942069","journal-title":"Front Psychiatry"},{"key":"ref68","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007849.pub2","article-title":"Acupuncture for autism spectrum disorders (ASD)","volume":"2011","author":"Cheuk DK","year":"2011","unstructured":"Cheuk DK, Wong V, Chen WX. Acupuncture for autism spectrum disorders (ASD). Cochrane Database Syst Rev. 2011, 2011:CD007849. 10.1002\/14651858.CD007849.pub2","journal-title":"Cochrane Database Syst Rev"},{"key":"ref69","doi-asserted-by":"publisher","DOI":"10.1038\/nrn3666","article-title":"Brain correlates of music-evoked emotions","volume":"15","author":"Koelsch S","year":"2014","unstructured":"Koelsch S. Brain correlates of music-evoked emotions. Nat Rev Neurosci. 2014, 15:170-80. 10.1038\/nrn3666","journal-title":"Nat Rev Neurosci"},{"key":"ref70","doi-asserted-by":"publisher","DOI":"10.1093\/cercor\/bhr084","article-title":"Functional and dysfunctional brain circuits underlying emotional processing of music in autism spectrum disorders","volume":"21","author":"Caria A","year":"2011","unstructured":"Caria A, Venuti P, de Falco S. Functional and dysfunctional brain circuits underlying emotional processing of music in autism spectrum disorders. Cereb Cortex. 2011, 21:2838-49. 10.1093\/cercor\/bhr084","journal-title":"Cereb Cortex"},{"key":"ref71","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2022.905113","article-title":"Effectiveness of music therapy in children with autism spectrum disorder: a systematic review and meta-analysis","volume":"13","author":"Ke X","year":"2022","unstructured":"Ke X, Song W, Yang M, Li J, Liu W. Effectiveness of music therapy in children with autism spectrum disorder: a systematic review and meta-analysis. Front Psychiatry. 2022, 13:905113. 10.3389\/fpsyt.2022.905113","journal-title":"Front Psychiatry"},{"key":"ref72","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004381.pub4","article-title":"Music therapy for autistic people","volume":"5","author":"Geretsegger M","year":"2022","unstructured":"Geretsegger M, Fusar-Poli L, Elefant C, M\u00f6ssler KA, Vitale G, Gold C. Music therapy for autistic people. Cochrane Database Syst Rev. 2022, 5:CD004381. 10.1002\/14651858.CD004381.pub4","journal-title":"Cochrane Database Syst Rev"},{"key":"ref73","doi-asserted-by":"publisher","DOI":"10.1186\/1866-1955-6-44","article-title":"The relationship between sleep and behavior in autism spectrum disorder (ASD): a review","volume":"6","author":"Cohen S","year":"2014","unstructured":"Cohen S, Conduit R, Lockley SW, Rajaratnam SM, Cornish KM. The relationship between sleep and behavior in autism spectrum disorder (ASD): a review. J Neurodev Disord. 2014, 6:44. 10.1186\/1866-1955-6-44","journal-title":"J Neurodev Disord"},{"key":"ref74","doi-asserted-by":"publisher","DOI":"10.1016\/j.sleep.2010.01.010","article-title":"Sleep in children with autistic spectrum disorder","volume":"11","author":"Cortesi F","year":"2010","unstructured":"Cortesi F, Giannotti F, Ivanenko A, Johnson K. Sleep in children with autistic spectrum disorder. Sleep Med. 2010, 11:659-64. 10.1016\/j.sleep.2010.01.010","journal-title":"Sleep Med"},{"key":"ref75","doi-asserted-by":"publisher","DOI":"10.3390\/s19204485","article-title":"The impact of technology on people with autism spectrum disorder: a systematic literature review","volume":"19","author":"Valencia K","year":"2019","unstructured":"Valencia K, Rusu C, Qui\u00f1ones D, Jamet E. The impact of technology on people with autism spectrum disorder: a systematic literature review. Sensors (Basel). 2019, 19:4485. 10.3390\/s19204485","journal-title":"Sensors (Basel)"},{"key":"ref76","doi-asserted-by":"publisher","DOI":"10.1016\/j.pnpbp.2021.110326","article-title":"The pediatric psychopharmacology of autism spectrum disorder: a systematic review - Part I: the past and the present","volume":"110","author":"Persico AM","year":"2021","unstructured":"Persico AM, Ricciardello A, Lamberti M, et al.. The pediatric psychopharmacology of autism spectrum disorder: a systematic review - Part I: the past and the present. Prog Neuropsychopharmacol Biol Psychiatry. 2021, 110:110326. 10.1016\/j.pnpbp.2021.110326","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"ref77","doi-asserted-by":"publisher","DOI":"10.1007\/7854_2022_330","article-title":"Current pharmacological treatments for ADHD","author":"Groom MJ","year":"2022","unstructured":"Groom MJ, Cortese S. Current pharmacological treatments for ADHD. New Discoveries in the Behavioral Neuroscience of Attention-Deficit Hyperactivity Disorder. Stanford SC, Sciberras E (ed): Springer International Publishing, Cham; 2022. 19-50. 10.1007\/7854_2022_330"},{"key":"ref78","doi-asserted-by":"publisher","DOI":"10.1111\/jcpp.13305","article-title":"Practitioner review: pharmacological treatment of attention-deficit\/hyperactivity disorder symptoms in children and youth with autism spectrum disorder: a systematic review and meta-analysis","volume":"62","author":"Rodrigues R","year":"2021","unstructured":"Rodrigues R, Lai MC, Beswick A, et al.. Practitioner review: pharmacological treatment of attention-deficit\/hyperactivity disorder symptoms in children and youth with autism spectrum disorder: a systematic review and meta-analysis. J Child Psychol Psychiatry. 2021, 62:680-700. 10.1111\/jcpp.13305","journal-title":"J Child Psychol Psychiatry"},{"key":"ref79","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-019-1835-1","article-title":"Pediatric sleep disturbances and treatment with melatonin","volume":"17","author":"Esposito S","year":"2019","unstructured":"Esposito S, Laino D, D'Alonzo R, et al.. Pediatric sleep disturbances and treatment with melatonin. J Transl Med. 2019, 17:77. 10.1186\/s12967-019-1835-1","journal-title":"J Transl Med"},{"key":"ref80","doi-asserted-by":"publisher","DOI":"10.1007\/112_2022_72","article-title":"Role of oxytocin in different neuropsychiatric, neurodegenerative, and neurodevelopmental disorders","volume":"186","author":"Ghazy AA","year":"2023","unstructured":"Ghazy AA, Soliman OA, Elbahnasi AI, Alawy AY, Mansour AM, Gowayed MA. Role of oxytocin in different neuropsychiatric, neurodegenerative, and neurodevelopmental disorders. Rev Physiol Biochem Pharmacol. 2023, 186:95-134. 10.1007\/112_2022_72","journal-title":"Rev Physiol Biochem Pharmacol"},{"key":"ref81","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-444-64012-3.00024-1","article-title":"The psychopharmacology of autism spectrum disorder and Rett syndrome","volume":"165","author":"Persico AM","year":"2019","unstructured":"Persico AM, Ricciardello A, Cucinotta F. The psychopharmacology of autism spectrum disorder and Rett syndrome. Handb Clin Neurol. 2019, 165:391-414. 10.1016\/B978-0-444-64012-3.00024-1","journal-title":"Handb Clin Neurol"},{"key":"ref82","doi-asserted-by":"publisher","DOI":"10.1007\/s40291-022-00600-7","article-title":"Modern biomarkers for autism spectrum disorder: future directions","volume":"26","author":"Jensen AR","year":"2022","unstructured":"Jensen AR, Lane AL, Werner BA, McLees SE, Fletcher TS, Frye RE. Modern biomarkers for autism spectrum disorder: future directions. Mol Diagn Ther. 2022, 26:483-95. 10.1007\/s40291-022-00600-7","journal-title":"Mol Diagn Ther"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/260777-emerging-treatments-and-therapies-for-autism-spectrum-disorder-a-narrative-review","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,2]],"date-time":"2024-07-02T15:28:58Z","timestamp":1719934138000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/260777-emerging-treatments-and-therapies-for-autism-spectrum-disorder-a-narrative-review"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,2]]},"references-count":82,"URL":"https:\/\/doi.org\/10.7759\/cureus.63671","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7,2]]}}}